Recent reports have suggested a link between single nucleotide polymorphisms (SNPs) in the OAS1 gene that strongly contribute to the prognosis of the disease46, implying that OAS1 may play a fundamental role in the ability of IFNs to treat multiple sclerosis. This evidence concerns the gene OAS1 and multiple sclerosis.